FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Riju Ray

Research Profile

Activities & Behaviors

Disorders

Tobacco Use Disorder

Chemicals & Drugs

Physiology

Occupations

Pharmacogenetics

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Procedures

Concepts & Ideas

Anatomy

Brain

Co-author Network

Publications

TOP 3
Mary Falcone; Allison B Gold; Julie A Blendy; Jacob Dubroff; Jean Logan; Andrew Newberg; Riju Ray; Kosha Ruparel; E Paul Wileyto; Jon K Zubieta; Caryn Lerman
μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief.
Mary Falcone; Christopher Jepson; Neal Benowitz; Andrew W Bergen; Angela Pinto; E Paul Wileyto; Don Baldwin; Rachel F Tyndale; Caryn Lerman; Riju Ray
Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers.
Riju Ray; Kosha Ruparel; Andrew B Newberg; E Paul Wileyto; James Loughead; Chaitanya Divgi; Julie A Blendy; Jean Logan; Jon K Zubieta; Caryn Lerman
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Riju Ray (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mary Falcone; Allison B Gold; Julie A Blendy; Jacob Dubroff; Jean Logan; Andrew Newberg; Riju Ray; Kosha Ruparel; E Paul Wileyto; Jon K Zubieta; Caryn Lerman
μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief.
Psychopharmacology 2012;222(4):701-8.
2011: Mary Falcone; Christopher Jepson; Neal Benowitz; Andrew W Bergen; Angela Pinto; E Paul Wileyto; Don Baldwin; Rachel F Tyndale; Caryn Lerman; Riju Ray
Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2011;13(6):498-503.
2011: Riju Ray; Kosha Ruparel; Andrew B Newberg; E Paul Wileyto; James Loughead; Chaitanya Divgi; Julie A Blendy; Jean Logan; Jon K Zubieta; Caryn Lerman
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(22):9268-73.
2010: Riju Ray; Nandita Mitra; Don Baldwin; Mengye Guo; Freda Patterson; Daniel F Heitjan; Christopher Jepson; E Paul Wileyto; Jinxue Wei; Thomas Payne; Jennie Z Ma; Ming D Li; Caryn Lerman
Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(6):1374-82.
2010: James Loughead; Riju Ray; E Paul Wileyto; Kosha Ruparel; Paul Sanborn; Steven J Siegel; Ruben C Gur; Caryn Lerman
Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
Biological psychiatry 2010;67(8):715-21.
2009: J Loughead; E Paul Wileyto; Jeffrey N Valdez; P Sanborn; Kathy Tang; Andrew Strasser; Kosha Ruparel; Riju Ray; Ruben C Gur; Caryn Lerman
Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype.
Molecular psychiatry 2009;14(8):820-6.
2009: Andrew B Newberg; Riju Ray; Joshua Scheuermann; Nancy Wintering; Janet Saffer; Alexander Schmitz; Richard Freifelder; Joel Karp; Caryn Lerman; Chaitanya R Divgi
Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent.
Nuclear medicine communications 2009;30(4):314-8.
2009: Riju Ray; Robert A Schnoll; Caryn Lerman
Nicotine dependence: biology, behavior, and treatment.
Annual review of medicine 2009;60():247-60.
2009: Riju Ray; Rachel F Tyndale; Caryn Lerman
Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes.
Journal of neurogenetics 2009;23(3):252-61.
2008: Daniel F Heitjan; David A Asch; Riju Ray; Margaret Rukstalis; Freda Patterson; Caryn Lerman
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.
The pharmacogenomics journal 2008;8(6):391-9.
2008: Riju Ray; James Loughead; Ze Wang; John Detre; Edward Yang; Ruben Gur; Caryn Lerman
Neuroimaging, genetics and the treatment of nicotine addiction.
Behavioural brain research 2008;193(2):159-69.
2008: Daniel F Heitjan; Mengye Guo; Riju Ray; E Paul Wileyto; Leonard H Epstein; Caryn Lerman
Identification of pharmacogenetic markers in smoking cessation therapy.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147B(6):712-9.
2008: Ze Wang; Riju Ray; Myles Faith; Kathy Tang; E Paul Wileyto; John A Detre; Caryn Lerman
Nicotine abstinence-induced cerebral blood flow changes by genotype.
Neuroscience letters 2008;438(3):275-80.
2007: Jennifer M Phillips; Steven J Siegel; Alexandra E Shields; Freda Patterson; Thomas J Gould; Andrew A Strasser; Riju Ray; Angela Pinto; Janet Audrain-McGovern; Margaret Rukstalis; Kenneth A Perkins; Julie A Blendy; Caryn Lerman
Translating basic science to improve pharmacotherapy for nicotine dependence.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2007;9 Suppl 4():S583-98.
2007: Riju Ray; Christopher Jepson; E Paul Wileyto; John Dahl; Freda Patterson; Margaret Rukstalis; Angela Pinto; Wade H Berrettini; Caryn Lerman
Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2007;9(11):1237-41.
2007: Riju Ray; Christopher Jepson; Paul Wileyto; Freda Patterson; Andrew Strasser; Margaret Rukstalis; Kenneth Perkins; Julie A Blendy; Caryn Lerman
CREB1 haplotypes and the relative reinforcing value of nicotine.
Molecular psychiatry 2007;12(7):615-7.
2007: Riju Ray; Robert A Schnoll; Caryn Lerman
Pharmacogenetics and smoking cessation with nicotine replacement therapy.
CNS drugs 2007;21(7):525-33.
2006: Riju Ray; Christopher Jepson; Freda Patterson; Andrew Strasser; Margaret Rukstalis; Kenneth Perkins; Kevin G Lynch; S O'Malley; Wade H Berrettini; Caryn Lerman
Association of OPRM1 A118G variant with the relative reinforcing value of nicotine.
Psychopharmacology 2006;188(3):355-63.
2006: John Dahl; Joseph F Cubells; Riju Ray; Andrew E Weller; Falk W Lohoff; Thomas N Ferraro; David W Oslin; Kyle M Kampman; Charles Dackis; Yilang Tang; Joel Gelernter; Henry R Kranzler; Charles P O'Brien; Wade H Berrettini
Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence.
Addiction biology 2006;11(1):76-83.
2005: Riju Ray; Glenn A Doyle; James J Crowley; Russell J Buono; David W Oslin; Ashwin A Patkar; Paolo Mannelli; Peter A DeMaria; Charles P O'Brien; Wade H Berrettini
A functional prodynorphin promoter polymorphism and opioid dependence.
Psychiatric genetics 2005;15(4):295-8.